Research and Development

The Research and Development team at Cara Therapeutics is dedicated to innovating and advancing new therapeutic candidates aimed at treating pruritus through the selective targeting of peripheral kappa opioid receptors. This multidisciplinary team, comprised of experts in scientific research, clinical strategy, and operational management, collaborates to optimize drug development processes, from initial discovery through clinical trials, ensuring alignment with regulatory standards and market needs.